BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2609870)

  • 1. "Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
    Mustakallio KK
    Acta Derm Venereol Suppl (Stockh); 1989; 146():201-2. PubMed ID: 2609870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
    Runne U; Kunze J
    Hautarzt; 1985 Jan; 36(1):40-6. PubMed ID: 3972578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments.
    de Mare S; Calis N; den Hartog G; van de Kerkhof PC
    Acta Derm Venereol; 1989; 69(5):449-51. PubMed ID: 2572119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short contact dithranol therapy: advantages of a stiff emulsifying ointment base.
    Walker GB; Harrison PV; Seville RH; Smith JF
    Br J Dermatol; 1989 Feb; 120(2):277-83. PubMed ID: 2647124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anthralin therapy of psoriasis--a retrospective study of 39 cases].
    Higashi K; Katayama I; Nishioka K; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):129-34. PubMed ID: 2746967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD; Voss M
    Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new treatment of outpatient psoriasis: short-term dithranol therapy].
    Schmidli J; Hunziker T; Krebs A
    Ther Umsch; 1986 Feb; 43(2):160-4. PubMed ID: 3961713
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of psoriasis with dithranol].
    Korstanje MJ
    Ned Tijdschr Geneeskd; 1992 Mar; 136(12):597-8. PubMed ID: 1552984
    [No Abstract]   [Full Text] [Related]  

  • 15. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis.
    Thune P; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():28-9. PubMed ID: 1585760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
    Gloor M; Graf R; Wirth H; Landau M
    Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urea in combination with dithranol in treating psoriasis vulgaris].
    Przybilla B; Kaudewitz P; Bieber K
    Hautarzt; 1989; 40 Suppl 9():54-7. PubMed ID: 2681078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.